A Compston

A Shetty

A Zimmer

AC Howlett

AE Bygrave

C Bolton

C Delarasse

C Teuscher

Carolyn Tanner

CS Wu

D Baker

D McHugh

David Baker

David L. Selwood

DL Smith-Bouvier

E de Lago

E Kozela

E Montero

E Zurita

F Docagne

F Wu

G Disanto

G Musumeci

G Paltser

G Pryce

G Wotherspoon

Gareth Pryce

Gavin Giovannoni

Gregory J. Michael

H Kataoka

HM Vesterinen

I Mendel

J Corey-Bloom

J Karlsson

J Palazuelos

JA Encinas

JB Davis

JH Slingsby

JK O'Neill

JL Croxford

JM Coquet

JP Zajicek

K Li

K Maresz

KM Spach

L Cristino

LM Olsson

LS Whyte

M Sundvall

M Webb

MF Festing

NA Balenga

NE Buckley

O Ofek

PC Staton

PD Fillmore

PM Hoi

RA Ross

RC Axtell

RG Pertwee

RJ Butterfield

Roberto Furlan

RS Graves

Ruth A. Ross

S Al-Izki

S Amor

S Katona

S Levine

S Rossi

S Saadoun

Samuel J. Jackson

SC Landis

SJ Allen

Sofia Sisay

V Devonshire

Y Okuda

ZY Lou

PLoS ONE

English

PubMed

Sisay Sofia

Pryce Gareth

Jackson Samuel J.

Tanner Carolyn

Ross Ruth A.

Michael Gregory J.

Selwood David L.

Giovannoni Gavin

Baker David

Public Library of Science (PLOS)

 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis

Sisay, S

Pryce, G

Jackson, SJ

Tanner, C

Ross, RA

Michael, GJ

Selwood, DL

Giovannoni, G

Baker, D

Queen Mary Research Online

Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis

Crossref

Endocannabinoids and some phytocannabinoids bind to CB1 and CB2 cannabinoid receptors, transient receptor potential vanilloid one (TRPV1) receptor and the orphan G protein receptor fifty-five (GPR55). Studies using C57BL/10 and C57BL/6 (Cnr2 (tm1Zim)) CB2 cannabinoid receptor knockout mice have demonstrated an immune-augmenting effect in experimental autoimmune encephalomyelitis (EAE) models of multiple sclerosis. However, other EAE studies in Biozzi ABH mice often failed to show any treatment effect of either CB2 receptor agonism or antagonism on inhibition of T cell autoimmunity. The influence of genetic background on the induction of EAE in endocannabinoid system-related gene knockout mice was examined. It was found that C57BL/6.GPR55 knockout mice developed less severe disease, notably in female mice, following active induction with myelin oligodendrocyte glycoprotein 35-55 peptide. In contrast C57BL/6.CB2 (Cnr2 (Dgen)) receptor knockout mice developed augmented severity of disease consistent with the genetically and pharmacologically-distinct, Cnr2 (tm1Zim) mice. However, when the knockout gene was bred into the ABH mouse background and EAE induced with spinal cord autoantigens the immune-enhancing effect of CB2 receptor deletion was lost. Likewise CB1 receptor and transient receptor potential vanilloid one knockout mice on the ABH background demonstrated no alteration in immune-susceptibility, in terms of disease incidence and severity of EAE, in contrast to that reported in some C57BL/6 mouse studies. Furthermore the immune-modulating influence of GPR55 was marginal on the ABH mouse background. Whilst sedative doses of tetrahydrocannabinol could induce immunosuppression, this was associated with a CB1 receptor rather than a CB2 receptor-mediated effect. These data support the fact that non-psychoactive doses of medicinal cannabis have a marginal influence on the immune response in MS. Importantly, it adds a note of caution for the translational value of some transgenic/gene knockout and other studies on low-EAE susceptibility backgrounds with inconsistent disease course and susceptibility

UCL Discovery

Samuel J Jackson

Ruth A Ross

Gregory J Michael

David L Selwood

Directory of Open Access Journals

Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.

<div>Endocannabinoids and some phytocannabinoids bind to CB1 and CB2 cannabinoid receptors, transient receptor potential vanilloid one (TRPV1) receptor and the orphan G protein receptor fifty-five (GPR55). Studies using C57BL/10 and C57BL/6 (Cnr2tm1Zim) CB2 cannabinoid receptor knockout mice have demonstrated an immune-augmenting effect in experimental autoimmune encephalomyelitis (EAE) models of multiple sclerosis. However, other EAE studies in Biozzi ABH mice often failed to show any treatment effect of either CB2 receptor agonism or antagonism on inhibition of T cell autoimmunity. The influence of genetic background on the induction of EAE in endocannabinoid system-related gene knockout mice was examined. It was found that C57BL/6.GPR55 knockout mice developed less severe disease, notably in female mice, following active induction with myelin oligodendrocyte glycoprotein 35-55 peptide. In contrast C57BL/6.CB2 (Cnr2Dgen) receptor knockout mice developed augmented severity of disease consistent with the genetically and pharmacologically-distinct, Cnr2tm1Zim mice. However, when the knockout gene was bred into the ABH mouse background and EAE induced with spinal cord autoantigens the immune-enhancing effect of CB2 receptor deletion was lost. Likewise CB1 receptor and transient receptor potential vanilloid one knockout mice on the ABH background demonstrated no alteration in immune-susceptibility, in terms of disease incidence and severity of EAE, in contrast to that reported in some C57BL/6 mouse studies. Furthermore the immune-modulating influence of GPR55 was marginal on the ABH mouse background. Whilst sedative doses of tetrahydrocannabinol could induce immunosuppression, this was associated with a CB1 receptor rather than a CB2 receptor-mediated effect. These data support the fact that non-psychoactive doses of medicinal cannabis have a marginal influence on the immune response in MS. Importantly, it adds a note of caution for the translational value of some transgenic/gene knockout and other studies on low-EAE susceptibility backgrounds with inconsistent disease course and susceptibility. </div

Sofia Sisay (468643)

Gareth Pryce (468644)

Samuel J. Jackson (468645)

Carolyn Tanner (468646)

Ruth A. Ross (468647)

Gregory J. Michael (468648)

David L. Selwood (468649)

Gavin Giovannoni (125820)

David Baker (11642)

The Francis Crick Institute

Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis

http://discovery.ucl.ac.uk/1414952/1/journal.pone.0076907.pdf

Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis

Abstract

Similar works

Full text

Available Versions

Public Library of Science (PLOS)

Queen Mary Research Online

Crossref

UCL Discovery

Directory of Open Access Journals

The Francis Crick Institute